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Abstract  Coronary  artery  perforation  (CAP)  is  a  rare  but  feared  complication  of  percutaneous
coronary  intervention.  With  the  advent  of  new  devices  and  technologies,  interventionalists
attempt  more  complex  lesions,  including  more  calcified  or  tortuous  vessels  and  chronic  total
occlusions, which  increases  the  incidence  of  CAP.  A  short  literature  review,  in  addition  to  four
cases of  CAP,  is  presented  in  this  report.






Perfurações  de  artérias  coronárias:  quatro  casos  diferentes  e  uma  revisão
Resumo  As  perfurações  das  artérias  coronárias  são  raras,  mas  complicações  temidas  nas
intervenções coronarianas  percutâneas.  Com  o  advento  de  novos  dispositivos  e  tecnologias,
a tentativa  de  intervenção  em  lesões  mais  complexas,  incluindo  os  vasos  mais  calcificados  ouIntervenção  coronária
percutânea tortuosos  ou  oclusões  crónicas,  leva  a  maior  incidência  de  perfurações  de  artérias  coronárias.
Uma breve  revisão  da  literatura,  além  de  quatro  casos  de  perfurações  de  artérias  coronárias
foi apresentada  no  presente  trabalho.
© 2013  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.∗ Corresponding author: Pamukkale University Hospital, Depart-
ment of Cardiology, Denizli/TURKEY.
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ife-threatening  complication  of  percutaneous  coronary
ntervention  (PCI).  Its  incidence  depends  on  the  mate-
ial  and  methods  for  visualizing  or  opening  the  coronary
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o the  vessel  wall  without  extravasation  (B);  control  angiogram
he ruptured  area.
rteries.  With  the  advent  of  new  devices  and  technologies,
nterventionalists  attempt  more  complex  lesions,  including
ore  calcified  or  tortuous  vessels.
The  first  patient  was  a  70-year-old  man  complaining  of
hest  pain  despite  medical  treatment.  Coronary  angiogra-
hy  (CAG)  was  performed  electively  with  a  diagnosis  of
table  angina  pectoris.  CAG  revealed  a  long,  angulated,
ccentric  critical  lesion  in  the  mid  right  coronary  artery
Figure  1A).  Direct  stenting  of  the  target  lesion  was  per-
ormed,  and  then  a  type  I  coronary  perforation  (limited  to
he  vessel  wall  without  extravasation)  was  detected  on  the
ngiogram  (Figure  1B).  Prolonged  balloon  inflation  only  was
pplied  to  the  ruptured  area  and  the  control  angiogram
howed  no  extravasation  (Figure  1C).  There  was  no  peri-
ardial  effusion  on  transthoracic  echocardigraphy  after  the
rocedure.
The  second  patient  was  a  58-year-old  woman  who  went
o  the  cardiology  outpatient  clinic  with  new-onset,  progres-
ive,  oppressive  chest  pain,  diagnosed  as  unstable  angina.
 long,  calcified,  eccentric  critical  lesion  was  detected  in
he  mid  to  distal  left  anterior  descending  (LAD)  coronary
rtery  during  CAG  (Figure  2A).  Stenting  of  the  target  lesion
as  performed  after  balloon  predilatation.  A  type  II  perfo-
ation  (showing  limited  extravasation  with  some  myocardial
lushing)  was  seen  on  CAG  (Figure  2B).  A  covered  stent  was
mmediately  implanted  to  cover  the  rupture  and  anticoag-
lation  was  reversed.  No  myocardial  blushing  was  seen  on
he  control  CAG  (Figure  2C).  A  mild  pericardial  effusion,  not





igure  2  A  long,  calcified,  and  eccentric  critical  lesion  in  the  m
I perforation  showing  limited  extravasation  with  some  myocardia
ngiogram after  covered  stenting  (C).wing  no  extravasation  (C)  after  prolonged  balloon  inflation  at
The  third  patient  was  a  47-year-old  man,  who  was
eferred  to  the  cardiology  clinic  with  chest  pain  on
xercise.  Since  exercise  stress  testing  showed  3-mm  hori-
ontal  ST-segment  depression  at  the  target  heart  rate,  CAG
as  scheduled.  A  long,  thin,  eccentric  and  calcified  criti-
al  lesion  was  seen  in  the  mid  circumflex  coronary  artery
uring  CAG  (Figure  3A).  Stenting  after  balloon  predilatation
as  planned,  but  a  type  III  coronary  rupture  (demonstrat-
ng  significant  contrast  streaming  into  the  pericardium)
as  observed  while  the  guidewire  was  being  advanced
Figure  3B).  Because  a  covered  stent  of  suitable  size  for  such
 thin  lesion  was  not  available  in  the  catheterization  labo-
atory,  the  patient  underwent  urgent  surgical  repair  with
rolonged  balloon  inflation  proximal  to  the  ruptured  area  to
revent  cardiac  tamponade.  In  addition,  reversal  of  antico-
gulation  therapy  was  achieved  by  protamine.
The  fourth  patient  was  a  74-year-old  woman  who  went
o  the  emergency  department  with  new-onset  severe  chest
ain  and  was  diagnosed  with  acute  anterior  myocardial
nfarction.  She  was  transferred  to  the  catheterization  labo-
atory  for  primary  PCI.  Long,  thin,  angulated  and  eccentric
ritical  sequential  lesions  with  thrombus  were  detected  in
he  mid  to  distal  portion  of  the  LAD  (Figure  4A).  After  sten-
ing  followed  by  balloon  predilatations,  prominent  contrast
ow  into  the  left  ventricle  was  detected  on  CAG,  indicating
ype  IV  coronary  rupture  (Figure  4B).  A  covered  stent  was
mmediately  implanted  in  the  ruptured  area  and  anticoag-
lation  was  reversed.  Control  CAG  showed  no  extravasation
round  the  target  area  (Figure  4C).  The  echocardiogram
id  to  distal  left  anterior  descending  coronary  artery  (A);  type
l  blushing  (B);  no  myocardial  blushing  is  seen  on  the  control



























Figure  3  A  thin,  long,  eccentric  and  calcified  critical  lesion  in
coronary rupture  demonstrating  significant  contrast  streaming  i
revealed  mild  pericardial  effusion  with  no  evidence  of  car-
diac  tamponade.
The  hemodynamic  parameters  of  all  of  these  patients
were  within  normal  limits  during  follow-up  and  they  were
discharged  fully  recovered  from  the  hospital.
Review
CAP  is  a  rare  but  feared  complication  of  PCI.  Its  incidence
varies  according  to  patient,  lesion  and  procedure  character-
istics;  studies  have  reported  incidences  ranging  from  0.29
to  3.0%.1,2 Risk  increases  with  the  complexity  of  the  lesions,
including  chronic  total  occlusions,  angulated  calcified  type
B2  and  type  C  lesions,  long  (>10  mm),  eccentric  lesions,
and  small  vessel  size.1--3 Older  age  and  previous  coronary
artery  bypass  graft  surgery  also  increase  the  risk.1,4,5 Risk
factors  include  conditions  associated  with  increased  calci-
fication  such  as  diabetes,  hypertension  and  chronic  renal
failure.4,6 Although  females  are  thought  to  be  more  prone
to  perforation  due  to  their  smaller  vasculature,  the  data  are
inconsistent.7,8
Ellis  et  al.  classified  coronary  perforations  based  on  their
angiographic  appearance.1 Type  I  perforations  are  limited
to  the  vessel  wall  and  produce  an  intramural  crater  without
extravasation  on  the  angiogram.  In  contrast  to  type  I,  types  II
and  III  are  not  limited  to  the  vessel  wall.  Type  II  perforations
show  limited  extravasation  with  pericardial  or  myocardial
blushing  on  angiography,  whereas  in  type  III  prominent  con-





Figure  4  Long,  thin,  angulated  and  eccentric  critical  sequential  
anterior descending  coronary  artery  (A);  type  IV  coronary  rupture  sho
angiogram showing  no  extravasation  around  the  target  area  after  co mid  circumflex  coronary  artery  (A);  guidewire-induced  type  III
he  pericardium  (B).
pilling  subtype  (type  IV  for  some  authors)  contrast  flow  can
e  seen  from  the  perforation  site  into  a  cardiac  chamber  or
avity,  such  as  the  left  ventricle  or  coronary  sinus,  rather
han  into  the  pericardium  or  myocardium.  Muller  et  al.  pro-
osed  adding  a  type  V  to  the  classification,  describing  distal
erforation  associated  with  the  use  of  hydrophilic  and/or
tiff  guides.9 Although  other  classifications  are  used,  Ellis’
s  the  most  widely  accepted.2,10,11
CAP  may  occur  with  the  use  of  guiding  catheters,
uidewires,  oversized  balloon/stents,  cutting  balloons,
ntravascular  ultrasound  (IVUS)  catheters,  or  debulking  tech-
iques,  or  following  balloon  rupture.3,12,13 A  significant
roportion  of  perforations  occur  with  guidewires  crossing
he  lesion,  with  distal  wire  perforation  or  wire  fracture.14
hysical  features  of  the  wire  affect  the  likelihood  of  CAP.
n  general,  stiffer  guides  increase  the  risk  of  perforation.
ikewise,  hydrophilic-coated  wires  have  been  found  to  be
ssociated  with  CAP  in  some  series.15,16 However;  this  may
eflect  either  use  of  these  low-friction  hydrophilic  coated
ires  to  facilitate  passage  through  more  complex  lesions  or
heir  ease  of  distal  migration.17
Perforations  occur  more  frequently  with  debulking  tech-
iques  than  with  non-debulking  techniques.  Considering  the
echanism  of  vessel  injury,  atheroablative  devices  often
ause  type  III  perforations.18 Perforation  is  more  likely
hen  IVUS  is  used,  probably  because  IVUS  is  frequently
sed  for  complex  lesions  or  when  PCI  is  complicated.19
hether  concomitant  administration  of  GP  IIb/IIIa  inhibitors
ncreases  the  likelihood  of  CAP  is  controversial,  since
ome  studies  show  increased  perforation  while  others  do
lesions  with  thrombus  in  the  mid  to  distal  portion  of  the  left
wing  prominent  contrast  flow  into  the  left  ventricle  (B);  control


























































































ot.4,19--21 This  may  be  a  selection  bias,  since  these  agents
re  generally  used  in  more  complicated  conditions,  but
nother  possible  explanation  is  that  they  may  unmask  a
inimal  vessel  tear  and  convert  it  to  overt  perforation.21
Therapeutic  strategies  include  prolonged  balloon  infla-
ion,  covered  stents,  reversal  of  anticoagulation,  emboliza-
ion  of  the  distal  vessel  and  surgery,  the  choice  depending
n  the  site  and  severity  of  the  perforation,  the  patient’s
emodynamic  status  and  the  equipment  available  in  the
atheterization  laboratory.8 Echocardiography  should  be
erformed  as  soon  as  a  perforation  is  identified.  If
ericardial  hemorrhage  or  hemodynamic  collapse  occur
ericardiocentesis  should  be  performed  immediately  with
ultiple  side  holes  for  continuous  aspiration,  after  which
he  drain  should  be  kept  in  place  for  6--24  hours  and  reac-
umulation  should  be  monitored  with  echocardiography.12
dministration  of  fluids  is  recommended.  A  balloon  should
mmediately  be  placed  with  inflations  lasting  up  to  5-
0  minutes  to  block  extravasation.  If  the  perforation  can-
ot  be  sealed,  repeated  inflations  should  be  made.  Distal
schemia  being  a  concern,  perfusion  balloons  can  be  used
ithout  blocking  distal  blood  flow.  Reversal  of  anticoagula-
ion  can  be  achieved  with  protamine.  As  previously  shown,
he  use  of  protamine  is  safe  and  does  not  predispose  to
tent  thrombosis.14,22 However,  diabetic  patients  on  pro-
amine  containing  insulin  and  patients  with  fish  allergy  are  at
ncreased  risk  for  protamine  reactions.  GP  IIb/IIIa  inhibitors
hould  also  be  discontinued  and  platelet  transfusions  should
e  used  if  needed.
Deployment  of  a  covered  stent  is  another  therapeutic
pproach,  especially  with  a  large  tear  involving  a  proximal
r  mid  coronary  artery.  Autologous  vein-covered  stents  have
een  used  successfully  in  the  past,23,24 but  this  technique
s  time-consuming  and  requires  expertise.  Polytetrafluo-
oethylene  (PTFE)  is  an  inert  and  biocompatible  polymer
omposed  of  carbon  chains  saturated  with  fluorine  and  in
ontrast  to  vein-covered  stents,  PTFE-covered  stents  are
asy  and  rapid  to  deploy.  However,  due  to  the  high  profile
nd  poor  flexibility  of  these  stents,  it  is  often  difficult  to
eliver  them  to  the  target  site,  especially  when  the  vessel
s  heavily  calcified  and  tortuous.25 The  use  of  IVUS  to  ensure
orrect  stent  implantation  and  final  high-pressure  balloon
nflation  may  improve  the  outcome.26 Pericardium-covered
tents  with  greater  flexibility  are  an  alternative  treatment,
lthough  experience  is  limited.27 Stent  thrombosis  and  in-
tent  restenosis  are  major  concerns  with  covered  stents,
s  is  side  branch  occlusion.19,25 Although  data  are  scarce,
rasugrel,  due  to  its  lack  of  intrinsic  resistance,  can  be  con-
idered  the  thienopyridine  of  choice  for  stent  thrombosis.28
nother  major  drawback,  the  time  elapsed  between  defla-
ion  of  the  sealing  balloon  and  the  final  delivery  of  the
overed  stent  to  the  lesion  site,  can  be  overcome  by  a  dual
atheter  technique.29
Alternative  therapies  used  in  selected  cases  include  coil
mbolization,  thrombogenic  particles  including  polyvinyl
lcohol,  gelfoam,  thrombin,  embolic  agents  like  N-butyl
yanoacrylate  glue,  and  autologous  blood  clot.30,31 Although
otentially  useful  in  emergency  situations,  these  agents
arry  a  risk  of  loss  of  the  vessel  lumen  and  subsequent  infarc-
ion.  Vessel  occlusion  techniques  should  therefore  be  used
s  a  last  resort  for  the  treatment  of  distal  perforations,  in
hich  the  potential  for  myocardial  injury  is  limited.30I.D.  Kilic  et  al.
If  a  large  perforation  causes  severe  ischemia  or  hemody-
amic  deterioration  or  cannot  be  sealed  with  the  available
echniques,  emergency  surgery  is  indicated.  Surgical  inter-
ention  may  be  life-saving,  but,  since  these  patients  have
ore  severe  perforations,  it  is  associated  with  higher  mor-
idity  and  mortality  and  worse  outcome.  Earlier  surgical
eferral  should  be  considered  in  this  context  when  dealing
ith  high-grade  perforations.6
onclusions
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